Since IL-6Rα and gp130 are required for signal transduction, the previous contradictory results may have been attributed to a lack of receptor expression in tested breast cancer cell lines, or that IL-6’s pleiotropic effects may depend on JAK/STAT3 pathway activation. This evidence concerns the gene IL6R and breast carcinoma.